RTS,S/AS01 Malaria Vaccine Efficacy is Not Modified by Seasonal Precipitation: Results from a Phase 3 Randomized Controlled Trial in Malawi

[1]  Juliana K. Wambua,et al.  Seven-Year Efficacy of RTS,S/AS01 Malaria Vaccine among Young African Children. , 2016, The New England journal of medicine.

[2]  Katya Galactionova,et al.  Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models , 2016, The Lancet.

[3]  O. Doumbo,et al.  Implementation of the malaria candidate vaccine RTS,S/AS01 , 2016, The Lancet.

[4]  David L. Smith,et al.  Distribution of malaria exposure in endemic countries in Africa considering country levels of effective treatment , 2015, Malaria Journal.

[5]  Yuming Guo,et al.  The effect of air pollution on human physiological function in China: a longitudinal study , 2015, The Lancet.

[6]  S. C. T. P. Rts.  Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial , 2015, The Lancet.

[7]  Peter G. Kremsner,et al.  Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. , 2015 .

[8]  Emmanuel Chanda,et al.  Scale-up of integrated malaria vector control: lessons from Malawi , 2015, Bulletin of the World Health Organization.

[9]  Jianwen Cai,et al.  Modelling recurrent events: a tutorial for analysis in epidemiology. , 2015, International journal of epidemiology.

[10]  D. Conway,et al.  Dynamics of the antibody response to Plasmodium falciparum infection in African children. , 2014, The Journal of infectious diseases.

[11]  M. Levin.  Medical Entomology for Students, 5th Edition , 2014, Emerging Infectious Diseases.

[12]  B. Greenwood,et al.  Efficacy and Safety of the RTS,S/AS01 Malaria Vaccine during 18 Months after Vaccination: A Phase 3 Randomized, Controlled Trial in Children and Young Infants at 11 African Sites , 2014, PLoS medicine.

[13]  Victor A Alegana,et al.  The changing risk of Plasmodium falciparum malaria infection in Africa: 2000–10: a spatial and temporal analysis of transmission intensity , 2014, The Lancet.

[14]  L. Kazembe,et al.  Mapping Malaria Transmission Intensity in Malawi, 2000–2010 , 2013, The American journal of tropical medicine and hygiene.

[15]  Kwaku Poku Asante,et al.  A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. , 2012, The New England journal of medicine.

[16]  Arantxa Roca-Feltrer,et al.  Estimating the potential public health impact of seasonal malaria chemoprevention in African children , 2012, Nature Communications.

[17]  Pedro Alonso,et al.  First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. , 2011, The New England journal of medicine.

[18]  J. Aponte,et al.  Statistical methodology for the evaluation of vaccine efficacy in a phase III multi-centre trial of the RTS , S / AS 01 malaria vaccine in African children , 2011 .

[19]  Anne Caroline Krefis,et al.  Modeling the relationship between precipitation and malaria incidence in children from a holoendemic area in Ghana. , 2011, The American journal of tropical medicine and hygiene.

[20]  A. Githeko,et al.  Association between climate variability and malaria epidemics in the East African highlands. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[21]  S. Hoffman,et al.  Seasonal malaria attack rates in infants and young children in northern Ghana. , 2002, The American journal of tropical medicine and hygiene.

[22]  A. V. Peterson,et al.  On the regression analysis of multivariate failure time data , 1981 .

[23]  Releve Epidemiologique Hebdomadaire.  Meeting of the Strategic Advisory Group of Experts on immunization, October 2015 – conclusions and recommendations. , 2015, Releve epidemiologique hebdomadaire.

[24]  J. Stockman.  First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children , 2013 .